Xeris Pharmaceuticals | XERS - DÍVIDA





DÍVIDA Alterar Data
Celltrion KRW 160.58B 733.3M 2026-03
Cspc Pharmaceutical CNY 641.11M 146.11M 2025-12
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Divis Laboratories Ltd INR 70M 30M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 8.2M 554K 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pharma Mar EUR 45.84M 1.7M 2026-06
Qiagen NV USD 1.65B 165.82M 2026-03
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Supernus Pharmaceuticals USD 40.9M 74K 2026-03
Tilray USD 640.95M 35.17M 2022-06
Zealand Pharma A/S 414M 8.23M 2026-03
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03